Journey Medical Corp. (DERM)
6.31
+0.36
(+6.05%)
USD |
NASDAQ |
Oct 09, 16:00
6.29
-0.02
(-0.32%)
After-Hours: 20:00
Journey Medical Enterprise Value : 174.41M for Oct. 9, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 09, 2026 | 174.41M |
| October 08, 2026 | 164.46M |
| October 07, 2026 | 164.46M |
| October 06, 2026 | 170.27M |
| October 05, 2026 | 184.92M |
| October 02, 2026 | 182.71M |
| October 01, 2026 | 185.75M |
| September 30, 2026 | 189.07M |
| September 29, 2026 | 179.39M |
| September 28, 2026 | 177.73M |
| September 25, 2026 | 169.71M |
| September 24, 2026 | 174.69M |
| September 23, 2026 | 179.67M |
| September 22, 2026 | 200.41M |
| September 21, 2026 | 193.22M |
| September 18, 2026 | 202.07M |
| September 17, 2026 | 203.45M |
| September 16, 2026 | 201.52M |
| September 15, 2026 | 203.45M |
| September 14, 2026 | 204.01M |
| September 11, 2026 | 199.86M |
| September 10, 2026 | 195.99M |
| September 09, 2026 | 205.94M |
| September 08, 2026 | 220.33M |
| September 04, 2026 | 217.28M |
| Date | Value |
|---|---|
| September 03, 2026 | 218.39M |
| September 02, 2026 | 214.79M |
| September 01, 2026 | 209.26M |
| August 31, 2026 | 204.84M |
| August 28, 2026 | 206.50M |
| August 27, 2026 | 208.16M |
| August 26, 2026 | 208.57M |
| August 25, 2026 | 208.16M |
| August 24, 2026 | 218.67M |
| August 21, 2026 | 214.24M |
| August 20, 2026 | 207.05M |
| August 19, 2026 | 188.24M |
| August 18, 2026 | 184.09M |
| August 17, 2026 | 178.56M |
| August 14, 2026 | 185.75M |
| August 13, 2026 | 183.82M |
| August 12, 2026 | 177.73M |
| August 11, 2026 | 174.69M |
| August 10, 2026 | 178.01M |
| August 07, 2026 | 177.73M |
| August 06, 2026 | 180.50M |
| August 05, 2026 | 176.90M |
| August 04, 2026 | 176.90M |
| August 03, 2026 | 178.84M |
| July 31, 2026 | 176.07M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| ANI Pharmaceuticals, Inc. | 1.932B |
| Corcept Therapeutics, Inc. | 12.78B |
| Veru, Inc. | 18.84M |
| Johnson & Johnson | 657.89B |
| Eli Lilly & Co. | 1.156T |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.312M |
| Revenue (Quarterly) | 18.51M |
| Total Expenses (Quarterly) | 18.82M |
| EPS Diluted (Quarterly) | -0.0114 |
| Gross Profit Margin (Quarterly) | 61.58% |
| Profit Margin (Quarterly) | -1.69% |
| Earnings Yield | -3.67% |
| Normalized Earnings Yield | -3.672 |